rs2239464

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001110792.2(MECP2):​c.62+14626C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 110,958 control chromosomes in the GnomAD database, including 5,993 homozygotes. There are 11,427 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.34 ( 5993 hom., 11427 hem., cov: 23)

Consequence

MECP2
NM_001110792.2 intron

Scores

1

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.113

Publications

29 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-154082978-G-A is Benign according to our data. Variant chrX-154082978-G-A is described in ClinVar as Benign. ClinVar VariationId is 3602015.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.756 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.62+14626C>T
intron
N/ANP_001104262.1
MECP2
NM_004992.4
MANE Plus Clinical
c.26+9206C>T
intron
N/ANP_004983.1
MECP2
NM_001316337.2
c.-422+9206C>T
intron
N/ANP_001303266.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.62+14626C>T
intron
N/AENSP00000395535.2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.26+9206C>T
intron
N/AENSP00000301948.6
MECP2
ENST00000496908.5
TSL:1
n.157+13835C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
37939
AN:
110907
Hom.:
5984
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.546
Gnomad AMI
AF:
0.0366
Gnomad AMR
AF:
0.451
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.780
Gnomad SAS
AF:
0.614
Gnomad FIN
AF:
0.196
Gnomad MID
AF:
0.340
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.369
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.342
AC:
37996
AN:
110958
Hom.:
5993
Cov.:
23
AF XY:
0.344
AC XY:
11427
AN XY:
33192
show subpopulations
African (AFR)
AF:
0.546
AC:
16625
AN:
30454
American (AMR)
AF:
0.452
AC:
4714
AN:
10425
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
630
AN:
2622
East Asian (EAS)
AF:
0.780
AC:
2743
AN:
3515
South Asian (SAS)
AF:
0.612
AC:
1579
AN:
2582
European-Finnish (FIN)
AF:
0.196
AC:
1170
AN:
5957
Middle Eastern (MID)
AF:
0.353
AC:
76
AN:
215
European-Non Finnish (NFE)
AF:
0.186
AC:
9858
AN:
52986
Other (OTH)
AF:
0.379
AC:
576
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
765
1531
2296
3062
3827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.254
Hom.:
15296
Bravo
AF:
0.374

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Rett syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.90
PhyloP100
-0.11

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239464; hg19: chrX-153348431; API